MolNFT v1 · #114938 · protein

Identification of a novel allosteric binding site for rorgt inhibitors

5C4O · Nuclear receptor ror-gamma: “Identification of a novel allosteric binding site for rorgt inhibitors”. X-ray diffraction, 2 ligands (4F1, SO4), 5 pockets (best druggability 0.82). MolNFT v1 #114938 on GenesisL1: 3D structure, binding…

PDB: 5C4O
Type: protein
Length: 241 residues
Chains: 1
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Nuclear receptor ror-gamma
UniProt: P51449
Ligands: 4F1, SO4
Pockets: 5 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 68% helix, 4% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Nuclear receptor ror-gamma	protein	241	68% helix, 4% strand	P51449

Ligands and binding sites

4F1 · 4-{1-[2-chloro-6-(trifluoromethyl)benzoyl]-1H-indazol-3-yl}benzoic acid · ligand · chains A
SO4 · Sulfate ion · ion · chains A
GOL · Glycerol · additive · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	379	0.82	0.90	38	GOL
2	201	0.80	0.94	27	4F1
3	173	0.53	0.79	20	empty
4	68	0.40	0.80	13	empty
5	95	0.35	0.74	19	empty

Compared structures

5C4O · Identification of a Novel Allosteric Binding Site for RORgt Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt P51449
Elsewhere: RCSB PDB 5C4O · PDBe 5C4O · UniProt P51449

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.